United States

Imprimis Pharmaceuticals Inc (IMMY.OQ)

IMMY.OQ on NASDAQ Stock Exchange Capital Market

23 Sep 2016
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for IMMY.OQ


Imprimis Pharmaceuticals, Inc. (Imprimis) is engaged in the development, production and dispensing of compounded pharmaceuticals. The Company operates through the business of developing drug therapies and providing such therapies through sterile and non-sterile pharmaceutical compounding services segment. The Company, through... (more)
No analyst recommendations are available for IMMY.OQ.


Beta: -0.46
Market Cap(Mil.): $50.35
Shares Outstanding(Mil.): 13.18
Dividend: --
Yield (%): --


  IMMY.OQ Industry Sector
P/E (TTM): -- 42.52 36.60
EPS (TTM): -1.71 -- --
ROI: -117.83 -0.26 13.91
ROE: -335.75 -3.05 14.82

BRIEF-Imprimis Pharmaceuticals implemented an expense reduction program

* Has ceased operations at its Texas facility and implemented an 8% reduction in total headcount

8:43am EDT

BRIEF-Imprimis Pharmaceuticals Q2 revenue $4.9 million

* Imprimis pharmaceuticals announces second quarter 2016 financial results

Aug 15 2016

BRIEF-Imprimis Pharmaceuticals $2 mln sale agreement with Essex Capital

* Agreement covers sale and leaseback of Imprimis' drug manufacturing equipment and has an initial term of up to three years

Aug 11 2016

BRIEF-Imprimis Pharmaceuticals Q1 loss per share $0.43

* Imprimis pharmaceuticals announces first quarter 2016 financial results and provides business update

May 12 2016

BRIEF-Imprimis Pharma says filed for registration of its ImprimisRx TX pharmacy

* Imprimis pharmaceuticals inc says filed for registration of its ImprimisRx TX pharmacy, in allen, texas , with fda as a 503b outsourcing facility Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

Apr 12 2016


  Price Chg
Eli Lilly and Co (LLY.N) $79.98 -1.18
Sanofi SA (SASY.PA) €67.59 -0.86
Bayer AG (BAYGn.DE) €89.20 -2.28
Bayer AG (BAYE.F) -- --
Roche Holding Ltd. (ROG.S) CHF242.10 -3.40
Roche Holding Ltd. (RO.S) CHF242.70 -2.90
Merck & Co., Inc. (MRK.N) $62.05 -0.91
Novartis AG (NOVN.S) CHF78.00 -1.15

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : ValuEngine, Inc.
Provider : Pechala's Reports
Provider : Reuters Investment Profile
Provider : Ford Investor Services, Inc.
Provider : GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.